Skip to main content
. 2021 Aug 18;13:17588359211039899. doi: 10.1177/17588359211039899

Figure 2.

Figure 2.

Both hypoxia and vascular endothelial growth factor (VEGF) promote immune tolerance via a number of mechanisms. This provides the rationale for immune checkpoint inhibitor (ICI) + VEGF inhibitor combinations in ovarian cancer (OC).